文档介绍：内置引流管加尿激酶治疗结核性包裹性胸腔积液60例临床分析
任水明张俊玲贺连珅韩勇
【摘要】目的探讨胸腔内留置深静脉管并注入尿激酶对结核性包裹性胸腔积液的治疗作用. 方法抗结核治疗下,常规胸腔内留置深静脉管引流胸水,治疗组胸腔内注入尿激酶10万U+生理盐水10ml/次,对照组胸腔内只注入生理盐水10ml/次. 结果尿激酶组总引流量明显优于对照组,遗留胸膜肥厚明显少于对照组,且无并发症发生. 结论内置引流管加尿激酶治疗结核性包裹性胸腔积液的方法方便,安全,疗效满意,值得在临床上推广应用.
Clinical analysis of 60 cases with the treatment of parcel tuberculous pleural effusion by using drain and intrapleral urokinase
REN shuiming ZHANG junling HE liansheng HAN yong
【Abstract】 Objective To explore therapeutic effects of parcel tuberculous pleural effusion by using drain and intrapleural urokinase. Methods The drainage of intravenous guttate was used. The therapy group used UK 100000u plus NS 10ml/ control group used NS 10ml/time in the thoracic cavity. Regular antituberculosis and prednisone treatment was used for all patients. Results The therapy group had less pleural incrassation than the control group,but had more drainage quantity than the control group. Neither had plications. Conclusion Using drainage in the method of intravenous guttate and intrapleral urokinase on the treatment of parcel tuberculous pleural effusion is a convenient and safe should be mended for a wider use.
结核性胸膜炎在我国是一种常见病、多发病,且经常易形成包裹性胸腔积液或脓胸。为了探讨结核性胸膜炎包裹性胸腔积液的有效治疗方法,作者采用常规胸腔内留置深静脉管引流胸腔积液及胸腔内注入尿激酶(UK)的方法,获的满意疗效,现报道如下。
1资料与方法
笔者选择2007年1月~2009年12月在我院初诊结核性胸膜炎60例患者,患者均符合以下入选标准⑴年龄在16~66岁、性别不限;⑵经临床及实验室检查证实为结核性胸膜炎,并且